Pituitary adenylate cyclase activating peptide (PACAP) is a vasoactive intestinal polypeptide (VIP)-like peptide recently isolated from ovine hypothalami. Nerve fibers containing PACAP immunoreactivity were present in the adventitia and the adventitia-media border of cat cerebral arteries. Double immunostaining revealed that P ACAP-immunoreactive nerve fibers constituted a sub popUlation of the VIP-containing fibers. PACAP effected a concentration-dependent relaxation of feline middle ce rebral arteries that had been pre contracted with prosta glandin Fzn. The maximum relaxation, 24 and 34% of Cerebral blood vessels are invested with a rich supply of nerve fibers containing noradrenaline, acetylcholine, and various neuropeptides (Uddman and Edvinsson, 1989) . The effects of adrenergic and cholinergic neurotransmitters in the regulation of cerebral blood flow are well established. The role of neuropeptides has not been fully evaluated due to the lack of established agonists and antagonists. Among the first neuropeptides to be detected around cerebral blood vessels was vasoactive intes tinal polypeptide (VIP), a 28-amino acid peptide with a widespread distribution in the peripheral ner vous system (Sundler et aI., 1988a). Fibers contain ing VIP have been demonstrated around cerebral blood vessels using immunohistochemical tech-
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In the present study, the distribution of PACAP immunoreactivity in feline cerebral arteries has been examined. Moreover, in view of the potency of PACAP as a stimulator of pituitary adenylate cy clase activity in hypothalamic extracts (Miyata et aI. , 1989) , the effects of PACAP upon feline cere bral blood vessels have been examined in vitro and the effects on cerebral blood flow upon local corti cal injection were examined in vivo.
MATERIALS AND METHODS

Immunohistochemistry
Pial vessels at the base of the brain were collected from five adult cats. The specimens were immersed in an ice cold fixative solution composed of 2% formaldehyde, buffered to pH 7.2 with 0.1 M phosphate buffer and 0.2% picric acid for 12 h. They were then rinsed in a Tyrode solution containing 10% sucrose for 48 h, frozen on dry ice, and sectioned in a cryostat at lO-fLm thickness. Some of the vessels and cortical pial membranes were fixed in a 0.1 M sodium phosphate-buffered solution of formalde hyde and picric acid overnight. They were then immersed in a Tyrode solution containing 10% sucrose for 48 h, briefly rinsed in phosphate buffer, and stretched on chrome-alum-subbed microscope slides as whole mounts. Cryostat sections and whole mounts were processed for the immunocytochemical demonstration of PACAP using the indirect immunofluorescence method (Coons, 1958) . The PACAP antiserum (code no. 88121-3) was raised in a rabbit against sheep PACAP-27 and used in a dilution of 1:640. The antiserum is directed against the C-terminal region of PACAP-27 but recognizes also PACAP-38 (Koves et ai., 1990) . Of the antisera against VIP, one was raised in a rabbit (code no. 7852; MILAB, Malmo, Swe den) and used in a dilution of 1 :640; another was raised in guinea pig (code no. 8701) and used in a dilution of 1 :640. The sections were exposed to the peptide antiserum for 24 h at 4°C in a moist chamber. The site of the antigen antibody reaction was revealed by application of fluores cein isothiocyanate (FITC)-labeled antibodies against im munoglobulin G (Dakopatts, Copenhagen, Denmark) in a dilution of 1 :320 for 1 h at room temperature. Control sections were exposed to antiserum that had been preab sorbed with an excess amount of the antigen (10-100 fLg synthetic peptide/ml diluted antiserum). Our absorption tests showed that the PACAP-27 antiserum does not cross-react with VIP, helodermin, bombesin, or sub- 1993 stance P. The VIP antisera used have been shown not to cross-react with other peptides such as glucagon, secre tin, helodermin, and gastric inhibitory peptide; neither do they cross-react with PACAP (10 fLg/ml of PACAP-27 added). However, cross-reaction with still other peptides or proteins sharing amino acid sequences with the exam ined peptide cannot be excluded. Therefore, it is appro priate to refer to the immunoreactive material as PACAP like or VIP-like. For brevity, however, the shorter terms PACAP and VIP will be used henceforth.
For double immunostaining the VIP antiserum raised in guinea pigs was used in combination with the P ACAP antiserum. Second antibodies were labeled with FITC and tetramethyl rhodamine isothiocyanate (TRITC), re spectively. Briefly, sections were first incubated with PACAP antiserum and with TRITC-Iabeled second anti bodies. The sections were then incubated with VIP an tiserum. Controls were run to exclude unexpected cross reactivity of the second antibodies. The sections were examined in a fluorescence microscope fitted with the appropriate filter settings for viewing TRITC and FITC fluorescence alternately.
Response of isolated pial arterial segments
Seven adult cats of either sex, weighing 2-4 kg, were exsanguinated under pentobarbitone anesthesia (Nembu tal 30 mg/kg i.p.). The brains were removed, and the mid dle cerebral arteries were dissected free and placed in a cold buffer solution aerated with 5% CO2 in 02' The com position of the buffer solution was as follows (mM): NaCI 119, KCI 4.6, CaCI2 1.5, MgCl2 1.2, NaHC0 3 15, NaH2P04 1.2, and glucose 11.0, pH 7.4. Vessel segments, 2-3 mm long, were mounted between two L-shaped metal prongs in a 2.5-ml mantled tissue bath at 37°C for record ing of circular vasomotor activity. Isometric tension was measured with Grass force-displacement transducers and recorded on a Grass polygraph. The segments were given a passive load of 3 mN and allowed to attain a steady level of tension and to stabilize for 90 min before testing with an elevated potassium buffer solution obtained by an equimolar substitution of NaCI for KCI, resulting in a potassium concentration of 60 mM. When relaxation of the vessels was being examined, the vascular segments were given an active tone by means of the addition of prostaglandin F2 ex (3 X 10-6 M). This resulted in a con traction that was stable for at least 30 min.
Analysis of cerebral blood flow
Four cats were anesthetized with a-chloralose (60 mg! kg i.p.), paralyzed (gallamine triethiodide, 6 mglkg i.v.), ventilated with a mixture of 60% air/40% °2, and placed in a stereotaxic device (David Kopf Instruments). End expiratory CO2 was continuously monitored and adjusted by altering the stroke volume of a ventilator (Harvard Instruments) and the fractional concentration of O2 in inspired gas (Fi02) continuously observed (Datex Instru ments). Arterial blood gases were measured during the study. Polyethylene catheters were placed in the femoral artery and vein bilaterally for measurement of blood pres sure (with a Statham pressure transducer) and adminis tration of drugs or fluids. The level of anesthesia was monitored by observing cardiovascular responses to no ciceptive stimuli and supplemental doses (l0 mg/kg a-chloralose) were administered at hourly intervals if re quired.
Laser-Doppler flowmetry
The principles of operation have been well described by Stern and colleagues (1977) and the application of the technique in this laboratory has also been recently de scribed (Goadsby, 1991) . Briefly, infrared light from a laser diode with a wavelength of 780 nm is directed to the surface of the brain via a fiber-optic cable. The cable contains two further fibers that detect backscatter from a tissue area of -1 mm 3 • Analysis of the Doppler shift caused by that portion of light scattered by the red blood cells gives the velocity of flow for those cells, while the proportion of light back scattered is directly related to the volume of moving red cells in the brain sampled. A flow index can thus be derived by multiplying these signals and represents cerebral cortical blood flow (CBFL DF ).
In these experiments the BPM 403A (TSI Inc.) instru ment was used with a pencil probe (P-433; TSI) mounted in a stereotaxic manipulator (David Kopf Instruments) and the signals for flow, velocity, and volume continu ously monitored. Biparietal craniotomies were carried out with a low-speed dental drill that was cooled with saline to prevent underlying thermal injury and the dura was left intact. Cerebrovascular reactivity to a brief pe riod of hypercapnia (6-8%) was tested before collecting data. Only data points collected from animals responsive to hypercapnia are included in this analysis. The blood pressure, heart rate, end-expiratory CO2, inspiratory O2, and laser-Doppler volume, flow, and velocity signals were passed to a signal-conditioning device and then to an analog-to-digital converter (LabMaster DMA; Scientific Solutions) in an 80286/80287-based microcomputer (A PC IV Powermate II; NEC). Data were monitored by aver aging over a respiratory pump cycle. All data were stored on disk for later analysis and plotting.
Local cortical injection
Solutions of either vehicle (phosphate-buffered saline) or PACAP were injected directly into the cortex in a vol ume of 1 fL1. The injections were made from a glass mi cropipette driven by a pressure-injecting system that was constructed in the laboratory. The volume was delivered over 5 min under the area of probe sampling with the glass pipette inclined so that the dura could be incised for its passage at a distance from the recording site. Cortical vascular reactivity was tested after pipette insertion and before the injections were made. PACAP was injected in doses of 0.05,0.5, and 5 fLg and the vehicle was injected in the same volume.
The CBFLDF data were converted to the percentage change from the previous baseline level for the calcula tions (Kaiser, 1989) . Data were analyzed using a single way analysis of variance and the Scheffe test (Miller, 1966) with a level of significance of p < 0.05.
Drugs
Atropine (ACO), cimetidine hydrochloride (Smith Kline & French), PACAP-38, PACAP-27 (Peninsula), propranolol (ICI), and prostaglandin F2a (Amoglandin, Astra, Sweden) were dissolved and diluted in saline just prior to experimentation. Concentrations are given as moles per liter.
RESULTS
Immunohistochemistry
A moderate supply of fine varicose nerve fibers containing PACAP immunoreactivity were regu-larly encountered in the adventitia and at the ad ventitia-media border of all pial arteries examined (Fig. I) . A richer supply of PACAP fibers was noted in pial vessels belonging to the rostral portion of the circle of Willis than in the more caudally located arteries. Few nerve fibers were observed in mate rial from the basilar artery and vertebral arteries. The small pial arteries and arterioles on the cortical surface received immunoreactive fibers, though to a lesser extent than the major cerebral arteries.
Double immunostaining revealed that a majority of the PACAP-immunoreactive nerve fibers con tained VIP. A subpopulation of the VIP fibers seemed to lack PACAP (Fig. 2) .
Responses of isolated middle cerebral arteries
Under resting conditions (i.e., when the arteries had reached a steady level of tension of -3 mN), PACAP-38 or PACAP-27 effected none or only a minimal relaxation of middle cerebral arteries. Ad ministration of prostaglandin Fzu resulted in a pro nounced, persistent contraction (4.9 ± 4.8 mN) (mean ± SD) of the vessels similar to the maximum contraction elicited by 60 mM K + (5.5 ± 4.2 mN) (n = 14). In vessel segments contracted with prosta glandin F2u, the administration of PACAP-38 or PACAP-27 00-11 _10-6 M) resulted in a concentra tion-dependent relaxation of the cerebral artery (Fig. 3) . The negative logarithm of the mean effec tive concentration of PACAP-38 and PACAP-27 was 7.87 ± 0.54 and 7.70 ± 0.95, respectively, and the maximum relaxation obtained in vessels with active tension induced by prostaglandin F2u was 24 ± 23 and 34 ± 14%, respectively, of precontract ion (n = 7). The presence of atropine 00-6 M), cimet idine (2 x 10-6 M), or propranolol 00-6 M) in the tissue bath did not affect the relaxation of middle cerebral arteries induced by the administration of PACAP-38.
Local cerebral blood flow
The cardiovascular and blood gas parameters for the animals included in the analysis were within the normal physiological range for the anesthetized cat.
Intracerebral injection of 1 fLl of phosphate buffered saline had no effect on CBFL DF with a mean change of 2 ± 4% in the flow signal. In con trast, injection of PACAP-38 in the same volume of solution had a moderate and consistent vasodilator effect on the cerebral circulation, the onset of which was rapid. Cerebral blood flow was increased in a concentration-dependent fashion above the level seen with the vehicle injection (p < 0 . 01). The mean maximum increase was 18.6 ± 6% at 5 fLg in 1 fLl (Fig. 4) . There was no significant effect on the con- tralateral flow signal, nor was there a consistent effect on peripheral cardiovascular parameters.
DISCUSSION
There is growing evidence that VIP-related pep tides besides VIP occur in the mammalian periph eral neuroendocrine system. Thus, helodermin-like immunoreactivity has been demonstrated in thyroid J Cereb Blood Flow Me/ab. Vol. /3, No.2, 1993 C cells, in noradrenaline cells of the adrenal me dulla, and in endocrine cells of the airways in a number of species (Sundler et aI., 1988b; Bjartell et aI., 1989; Luts et aI., 1990) . Recently, PACAP, an other VIP-related peptide, was isolated from sheep hypothalami, sequenced (Miyata et aI., 1989 (Miyata et aI., , 1990 , and found to occur in neuronal elements in the brain (K6ves et aI., 1990; Kivipelto et aI., 1991) . PACAP- immunoreactive cell bodies were located in hypo thalamic nuclei and in the central gray, whereas moderate densities of PACAP-immunoreactive fi bers were seen in the median eminence, neurohy- There is no effect of vehicle phosphate-buffered saline, nor does PACAP injection affect flow contralaterally after a sin gle intracortical injection. There is a moderate consistent concentration-related vasodilator response to PACAP injec tion.
pophysis, central amygdala, and periaqueductal gray of the rat (Kaves et aI., 1990; Kivipelto et aI., 1991) . Preliminary immunochemical and immuno cytochemical observations indicate the presence of PACAP immunoreactivity in neuronal elements in several peripheral organs, including the respiratory tract and the gut (Sundler et aI., 1991; U ddman et aI., 1991) . Furthermore, a high density of PACAP binding sites has been observed in lung membranes of the rat (Gottschall et aI., 1990 ).
In the present study, few to a moderate supply of PACAP-containing fibers was seen around cerebral blood vessels. In contrast, a dense supply of VIP containing nerve fibers is present in the walls of cerebral blood vessels (Larsson et aI., 1976; Ed vinsson et aI., 1980; Matsuyama et aI., 1983) . Dou ble immunostaining revealed that the majority of the PACAP-immunoreactive fibers, in addition, stored VIP. Antiserum-directed PACAP-27 was used for immunohistochemical localization. PACAP-27 and PACAP-38 cross-react at the immu nocytochemical level. Thus, the identity of the PACAP-27-like peptides observed around cerebral blood vessels is still unclear. The fact that the an tiserum against PACAP-27 cross-reacts with PACAP-38 and vice versa prevents a firm conclu sion about whether the immunoreactivities against the two peptides are two separate or one single pep tide cross-reacting with the antisera.
A number of investigations have pointed toward a possible role for peptides in the control of cerebral tissue perfusion. VIP can elicit the dilatation of ce rebral arteries (Larsson et aI., 1976; Bevan et aI., 1984) and pial arterioles (McCulloch and Edvins son, 1980) . The systemic administration of VIP re sults in large increases in cerebral blood flow, al though the interpretation of the primary mechanism underlying this vasodilatation is complicated by the concomitant alterations in cerebral metabolic activ ity (McCulloch and Edvinsson, 1980) .
In the present study, PACAP-38 and PACAP-27 were shown to induce concentration-dependent re laxation of isolated middle cerebral arteries. There was no difference in response between the long and short forms of PACAP in either mean effective con centration or maximum response. The mean effec tive concentration was also comparable with that previously shown for VIP (Larsson et aI., 1976) , although the magnitude of the maximum relaxation was slightly lower for PACAP-38 than for VIP. The minimum effective concentration of both PACAP-38 and VIP in eliciting dilatations is considerably lower than those of monoamines examined under similar conditions (see Edvinsson and MacKenzie, 1976) . The dilatatory effect of PACAP would not appear to be mediated by histaminergic H2, cholin ergic, or [3-adrenergic receptors, all of which are known to be present in cerebral blood vessels (Ed vinsson and MacKenzie, 1976) , since the response to PACAP-38 was unaffected by the presence of cimetidine, atropine, or propranolol, respectively. Cortical injection of PACAP-38 caused a moderate but consistent increase in local cerebral perfusion. The in situ responses complement the in vitro ob servations and extend the observations of the cere brovascular motor effects of PACAP-38 to an in vivo condition as well as avoiding the necessity to contract the vessels actively with prostaglandins as was the case in vitro. Like VIP, PACAP-38 may induce vasodilatation when injected in anesthetized rats. PACAP-38 shows a 1,000 times more potent pituitary adenylate cyclase stimulating activity in hypothalamic extracts as compared to VIP (Miyata et al., 1989) . We suggest that the present data pro vide the basis for a functional role of PACAP in the neuronal regulation of the cerebral blood flow.
